AlternativeMed
Relationship Graph Explorer

Follow the connections

Every herb, ingredient, formula, gene target, and disease — connected through real research. Search, pick a subject, and navigate the graph in any direction.

Plus 6,743 TCM formulas connecting herbs together
⚗️ Ingredient

Vitamin k

2
Clinical Trials
77
Meta-Analyses
0
PubMed References
📋 Sample Trials
NCT05360342
Incorporation of Vitamin K Into Uremic Lipoproteins
Completed
NCT05742295
Prevention of Cefoperazone-induced Coagulopathy
Completed · Phase 4
📊 Sample Meta-Analyses
CRD42017060344
A systematic review and meta-analysis of the effect of vitamin K supplementation on vascular health
Vitamin K is necessary for correct function of enzymes involved in bone metaboli
CRD42018087492
Does oral vitamin K supplementation reduce bone loss and prevent fractures in adults? An update
Fractures and bone density changes in adults.
CRD42021251825
The combined efect of vitamin K and calcium on bone mineral density in humans: a meta-analysis of randomized controlled trials
Endocrinology, Bone health. Osteoporosis, the most common bone disease character
📚 Sample References
None linked yet.
⚗️ All Ingredient data fields for Vitamin k
⚗️ Identity
Name
Vitamin k
Aliases / Synonyms
12001-79-5; 81818-54-4; Kephton; 2-methyl-3-[(E)-3,7,11,15-tetramethylhexadec-2-enyl]naphthalene-1,4-dione; Vitamin K1(20); .alpha.-Phylloquinone; 2-methyl-3-(3,7,11,15-tetramethylhexadec-2-en-1-yl)naphthalene-1,4-dione; 2-methyl-3-(3,7,11,15-tetramethylhexadec-2-enyl)naphthalene-1,4-dione; (E)-2-Methyl-3-(3,7,11,15-tetramethylhexadec-2-en-1-yl)naphthalene-1,4-dione
🧪 Chemistry
Molecular Weight
450.7070
LogP
9.1576
Drug-likeness
0.265
H-Bond Acceptors
2
Rotatable Bonds
14
🔬 Structures
Canonical SMILES
CC1=C(C(=O)C2=CC=CC=C2C1=O)CC=C(C)CCCC(C)CCCC(C)CCCC(C)C
Isomeric SMILES
CC1=C(C(=O)C2=CC=CC=C2C1=O)C/C=C(\C)/CCCC(C)CCCC(C)CCCC(C)C
InChIKey
MBWXNTAXLNYFJB-LKUDQCMESA-N
InChI
InChI=1S/C31H46O2/c1-22(2)12-9-13-23(3)14-10-15-24(4)16-11-17-25(5)20-21-27-26(6)30(32)28-18-7-8-19-29(28)31(27)33/h7-8,18-20,22-24H,9-17,21H2,1-6H3/b25-20+
🔗 External References
PubChem CID
DrugBank
NPASS
NPC1682
SymMap
18325
TCMID
23288
TCM-ID
9858
🔍 Raw view — every non-empty column on this row (31 fields)
name
Vitamin k
common names
12001-79-5; 81818-54-4; Kephton; 2-methyl-3-[(E)-3,7,11,15-tetramethylhexadec-2-enyl]naphthalene-1,4-dione; Vitamin K1(20); .alpha.-Phylloquinone; 2-methyl-3-(3,7,11,15-tetramethylhexadec-2-en-1-yl)naphthalene-1,4-dione; 2-methyl-3-(3,7,11,15-tetramethylhexadec-2-enyl)naphthalene-1,4-dione; (E)-2-Methyl-3-(3,7,11,15-tetramethylhexadec-2-en-1-yl)naphthalene-1,4-dione
herb ingredient id
HBIN048067
canonical smiles
CC1=C(C(=O)C2=CC=CC=C2C1=O)CC=C(C)CCCC(C)CCCC(C)CCCC(C)C
isomeric smiles
CC1=C(C(=O)C2=CC=CC=C2C1=O)C/C=C(\C)/CCCC(C)CCCC(C)CCCC(C)C
inchi
InChI=1S/C31H46O2/c1-22(2)12-9-13-23(3)14-10-15-24(4)16-11-17-25(5)20-21-27-26(6)30(32)28-18-7-8-19-29(28)31(27)33/h7-8,18-20,22-24H,9-17,21H2,1-6H3/b25-20+
inchikey
MBWXNTAXLNYFJB-LKUDQCMESA-N
mol wt
450.7070
num h acceptors
2
num h donors
0
mol logp
9.1576
num rotatable bonds
14
drug likeness
0.265
symmap mol id
18325
tcmid ingredient id
23288
tcm id ingredient id
9858
pubchem cid
5280483
drugbank id
DB01022
npass id
NPC1682

🏥 Linked Health Topics

1 · diseases via target pathways

📋 Clinical Trials

2 · subject of clinical study
NCT05360342 Incorporation of Vitamin K Into Uremic Lipoproteins
→ Vitamin K Deficiency
NCT05742295 Prevention of Cefoperazone-induced Coagulopathy
→ Antibiotic Side Effect

📊 Meta-Analyses

12 · systematic review
CRD42017060344 A systematic review and meta-analysis of the effect of vitamin K supplementation
→ Vitamin K is necessary for correct function of enz
CRD42018087492 Does oral vitamin K supplementation reduce bone loss and prevent fractures in ad
→ Fractures and bone density changes in adults.
CRD42021251825 The combined efect of vitamin K and calcium on bone mineral density in humans: a
→ Endocrinology, Bone health. Osteoporosis, the most
CRD42022300362 Impact of Different Forms of Vitamin K, Calcium, Vitamin D, or Their Combination
→ Osteoporosis.
CRD42017078915 Non-vitamin K oral anticoagulants in patients with atrial fibrillation: an overv
→ Anticoagulant therapy in patients with atrial fibr
CRD42020159237 Non-vitamin K antagonist oral anticoagulants versus warfarin for the secondary s
→ Atrial fibrillation. Ischemic stroke. Secondary pr
CRD42018099851 The safety and efficacy of vitamin K antagonists in women compared to those in m
→ Non-valvular atrial fibrillation.
CRD42018110497 Efficacy and safety of non-vitamin K antagonist oral anticoagulants (NOACs) in e
CRD42019118812 Anticoagulation control in patients on vitamin K antagonists in Africa: a system
→ Anticoagulation control in patients on vitamin K a
CRD42016038485 The impact of additional vitamin K, post antibiotic use, in patients with kidney
→ Renal disease
CRD42020197361 Systematic review analysis to review the efficacy of warfarin reversal with vita
→ Neck of femur / Hip fracture patients are elderly
CRD42020178771 Non-vitamin K antagonist oral anticoagulants versus warfarin for prevention of s
→ Stroke and bleeding in patients with atrial fibril
How relationships are computed
  • Clinical Trials / Meta-Analyses / References: direct foreign-key link via subject_entity_id (Phase 2d wireup)
  • Formula ↔ Herbs: text bridge via formulas.herbs_in_pinyin matching herbs.pinyin_name
  • Herb ↔ Ingredient: ACTIVE — direct link via herb_ingredients
  • Ingredient ↔ Target: ACTIVE — direct link via ingredient_targets
  • Target ↔ Disease: ACTIVE — direct link via target_health_topics
  • Herb → Target → Disease (full chemical spine): ACTIVE — joins all three link tables